Curious about United Therapeutics (UTHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics

In its upcoming report, United Therapeutics (UTHR) is predicted by Wall Street analysts to post quarterly earnings of $6.16 per share, reflecting an increase of 14.5% compared to the same period last year. Revenues are forecasted to be $718.06 million, representing a year-over-year increase of 17.8%. Over the last 30 days, there has been an upward revision of 0.4% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of ...